Leveraging mHealth to Promote Recovery From Opioid Use Disorder and Commonly Occurring Mental Health Disorders Among Residents of a Medium-Sized Midwestern City
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 300
- 试验地点
- 1
- 主要终点
- Abstinence/ Changes in Substance Use
研究概览
简要总结
The sequential trial compares recovery and mHealth engagement outcomes among Black participants who participated in the mHealth intervention uMAT-R or uMAT-R + enhanced community engagement. The mHealth intervention seeks to support people in various stages of recovery who are also seeking other forms of substance use treatment. Participants are recruited from community-based substance use treatment facilities and recovery services. Participants must be adults who have or are currently using opioids and/or stimulants.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Sequential
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Have a history of opioid and/or stimulant use
- •Identify as Black and/or African American
- •Seek treatment at local substance use treatment centers
- •Fluent in English
- •U.S. resident
- •18 years of age or older at the time of data collection.
排除标准
- •Self-reported cognitive impairment that would limit ability to participate in research.
研究组 & 干预措施
uMAT-R + enhanced community engagement
uMAT-R + enhanced community engagement involves an optimized community engagement strategy employed by the intervention team.
干预措施: uMAT-R + enhanced community engagement (Behavioral)
Original uMAT-R supplementary mHealth recovery intervention
uMAT-R supplementary mHealth recovery intervention is the original intervention disseminated without optimization of the community engagement approach.
干预措施: Original uMAT-R supplementary mHealth recovery intervention (Behavioral)
结局指标
主要结局
Abstinence/ Changes in Substance Use
时间窗: Time 0 (Baseline) and Time 1 (One Month)
Frequency of opioid use, stimulant, and/or other substance use (e.g., discordant with prescribed usage) or other substances (e.g., stimulants, other non-opioid illicit drugs) in the past 30-day will be assessed by items from the National Survey on Drug Use and Health (NSDUH) questionnaire. The score indicates days on using any substance listed above over past 30-day, ranging from 0 to 30, with a higher score reflecting more frequent substance use.
Opioid use/ Stimulant use disorder symptoms
时间窗: Time 0 (Baseline) and Time 1 (One Month)
The number of DSM-5-TR diagnostic criteria met for opioid use disorder (OUD) and stimulant use disorder (StUD) will be assessed. Scores range from 0 to 11, with higher scores indicating that more diagnostic criteria are met for the disorder.
次要结局
- Depression symptoms(Time 0 (Baseline) and Time 1 (One-Month))
- Anxiety Symptoms(Time 0 (Baseline) and Time 1 (One-Month))
- Basic needs(Time 0 (Baseline) and Time 1 (One-Month))
- Medication for Opioid Use Disorder (MOUD) Attitudes(Time 0 (Baseline), and Time 1 (One-Month))
- Substance Use Disorder (SUD) Treatment Engagement(Time 0 (Baseline), and Time 1 (One-Month))